PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.

Zehua WuYuanzhe ZhangYi ChengJianxia LiFangqian LiChao WangLishuo ShiGe QinWeixiang ZhanYue CaiXiaoyu XieJiayu LingHuabin HuJianwei ZhangYanhong Deng

Published in: Med (New York, N.Y.) (2024)

Funded by the National Natural Science Foundation of China (81974369) and the program of Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004).

Keyphrases

metastatic colorectal cancer
quality improvement
public health
study protocol
phase iii
clinical trial
phase ii
copy number
open label
placebo controlled